PFIZER PFE STUDIES DRUG AS WEIGHT LOSS TOOL NEW YORK March Pfizer Inc said it expects to file a new drug application in the U S and in other markets this year for sertraline a treatment for depression In its annual report Pfizer said that in addition to the drug s anti depressant action sertraline is currently undergoing studies to explore its ability to promote weight loss Company officials were not immediately available to comment further Eli Lilly and Co s LLY Prozac an antidepressant awaiting marketing approval has shown promise in promoting weight loss Pfizer also said it plans to file for U S marketing approval for certrizine a novel antihistamine for hay fever and other allergic reactions In Pfizer earned mln dlrs or dlrs per share on revenues of billion dlrs Reuter